Guidelines

These practice guidelines follow the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, which brings together groups and individuals throughout the world, with the goal of improving the ultrasound assessment of the fetal Central Nervous System (CNS) anatomy.

For further information: [email protected]e.org 

The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation

Themistoklis Dagklis, Cihat Şen, Ioannis Tsakiridis, Cecilia Villalaín, Karel Allegaert, Sven Wellmann, Satoshi Kusuda, Bernat Serra, Manuel Sanchez Luna, Erasmo Huertas, Nicola Volpe, Rodrigo Ayala, Nelly Jekova, Amos Grunebaum, Milan Stanojevic
Online publication date: February 06, 2022 DOI:10.2399/prn.22.0301004
Abstract
This practice guideline follows the mission of the World Association of Perinatal Medicine (WAPM) in collaboration with the Perinatal Medicine Foundation (PMF), bringing together groups and individuals throughout the world with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and also serves as a guideline for use in clinical practice.

 The use of antenatal corticosteroids for fetal maturation in COVID-19: clinical practice statement by WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation

Themistoklis Dagklis, Cihat Şen, Ioannis Tsakiridis, Cecilia Villalaín, Karel Allegaert, Sven Wellmann, Satoshi Kusuda, Bernat Serra, Manuel Sanchez Luna, Erasmo Huertas, Nicola Volpe, Rodrigo Ayala, Nelly Jekova, Amos Grunebaum, Milan Stanojevic
Online publication date: February 06, 2022 DOI:10.2399/prn.22.0301005
 
Abstract
This statement follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation in Coronavirus Disease 2019 (COVID-19). Pregnant women with COVID-19 are at increased risk of hospitalization, admission to intensive care unit and mechanical ventilation compared to non-pregnant patients. 

WAPM-World Association of Perinatal Medicine practice guidelines: fetal central nervous system examination

Valentina De Robertis, Cihat Şen, Ilan Timor-Tritsch, Rabih Chaoui, Paolo Volpe, Alberto Galindo, Reuven Achiron, Ritsuko Pooh, Asma Khalil, Nicola Volpe, Francesco D’Antonio, Roee Birnbaum
Online publication date: June 06, 2021 DOI:10.2399/prn.21.0292003
 
Abstract
These practice guidelines follow the mission of the World Association of Perinatal Medicine (WAPM) in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the ultrasound assessment of the fetal central nervous system (CNS) anatomy. In fact, this document provides further guidance for healthcare practitioners for the evaluation of the fetal CNS during the mid-trimester ultrasound scan with the aim to increase the ability in evaluating normal fetal anatomy. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world, and serves as a guideline for use in clinical practice.

Covid-19 Study Group

With Covid-19 outbreak in these days in every country, we do try our best to overcome all problems by not just taking care of our patients at the hospital but also save and protect ourselves and our beloved ones from Covid-19. Covid-19 is challenging everything and everyone into different directions. But we have to keep ourselves active and productive even in these hectic days in our daily life. I hope you are doing well with your loved one(s).

These guidelines follow the mission of the World Association of Perinatal Medicine, which brings together groups and individuals throughout the world with the goal of improving outcomes of maternal, fetal and neonatal (perinatal) patients. Guidelines for auditing, evaluation,
and clinical care in perinatal medicine enable physicians diagnose, treat and follow-up of COVID-19-exposed pregnant women. These guidelines are based on quality
evidence in the peer review literature as well as the experience of perinatal expert throughout the world. Physicians are advised to apply these guidelines to the local realities which they face.We plan to update these guidelines as new evidence become available

Download

Guideline for the use of antenatal corticosteroids for fetal maturation*

Women at risk of preterm birth before 34 weeks’ gestation are routinely given a course of antenatal corticosteroids (ACS) because there is good evidence that treatment reduces neonatal death, respiratory distress syndrome (RDS) and intraventricular hemorrhage (IVH)

Abstract

The aim is to present a document, which is based on current evidence and serves as a guideline for use in clinical practice. The following questions are addressed: • Is the use of antenatal corticosteroids (ACS) an effective therapy? • Who are the candidates for antenatal corticosteroid therapy? • Is there benefit after 34 weeks’ gestation? • When is the optimal time to treat? • Which are the optimal steroids; what is the ideal dose and route of administration? • Are there any contraindications to the administration of ACS? • Are antenatal corticosteroids indicated in women with premature rupture of membranes (PROM)? • Is the use of ACS recommended in pregnancies complicated by maternal diabetes mellitus? • Should the treatment with corticosteroids be repeated?

Download document

Recommendations Guidelines

The last publication of the WAPM (in cooperation with other scientific societies), Recommendations and Guidelines for Perinatal Medicine, was presented during the Congress in Florence.

INTRODUCTION

The term perinatology was introduced in 1936 by the German paediatrician Pfaundler to defi ne a period around the birth, characterize by a high fetal and neonate mortality, but with death causes different from those observed in older infants1. Perinatal medicine has as aim to improve the quality of life from its beginnings, through the fetal and newborn care. A precise terminology is required in order to describe all the events associated with perinatal outcome. International comparison of perinatal and neonatal mortality and its components is important. That information allows identifying problems, tracking temporal and geographical trends and disparities and assessing changes in public health policy and practice

Download document

Abstract Submission

Language of the presentation and the abstract is English. By submitting this presentation, I do accept that all abstracts accepted for presentation will be published in a supplement of Perinatal Journal on the authors' own responsibility and to transfer the copyright of the abstract to Perinatal Journal . Please be informed for more details from www.perinataljournal.com. By submission of your abstract/poster/video presentations, you do accept that all or a portion of presentations, comments, documents and presentation slides/videos presented will be recorded and may be selected for a recorded and on demand web portal for members and other user